Tag: Enzymes

Recent clinical studies have shown that a combination of proteolytic enzymes and antioxidants can provide a more effective solution for pain and inflammation compared to single-agent treatments. This is the principle behind the medication, **Disperzyme**, a combination drug used to relieve musculoskeletal pain, swelling, and inflammation associated with various conditions.

Recent analysis shows that over 95% of known drug targets are proteins [1.3.1]. These proteins facilitate how medications work, but what are the four main targets for drug action that are most crucial for therapeutic effects? [1.2.1, 1.2.4]

Approximately 80-90% of individuals with cystic fibrosis (CF) develop pancreatic insufficiency, where thick mucus blocks the pancreas from releasing digestive enzymes. To combat the resulting malabsorption and malnutrition, the primary treatment involves pancreatic enzyme supplements, which is the answer to the question: **What are enzymes for cystic fibrosis?**.

Approximately 90% of ingested alcohol is metabolized by the liver, with the remaining 10% eliminated through breath, urine, and sweat. Understanding what metabolises alcohol faster is crucial, as the rate is determined by a complex interplay of genetic and biological factors that cannot be rushed.

It is estimated that medication errors affect millions of people worldwide, so it is crucial to clarify drug names; while there is no medication called 'caramel Forte', it is a common mix-up for the widely prescribed proteolytic enzyme tablet, Chymoral Forte, which is used to reduce pain and swelling after injury or surgery. This medication works by promoting faster wound healing and easing discomfort.

In Japan, a long-standing tradition of consuming the fermented soybean dish natto is linked to a lower risk of cardiovascular disease and a longer average lifespan. This remarkable effect is largely attributed to the enzymes nattokinase and serrapeptase, a powerful combination known as natto Serra, which has garnered significant interest for its potential health benefits.

According to the CDC, cardiovascular disease is the leading cause of death in the United States, and blood clots are a major contributing factor. This has led to an increased interest in natural alternatives like lumbrokinase. But **can lumbrokinase dissolve blood clots?** Research suggests that this potent enzyme, derived from earthworms, possesses significant fibrinolytic activity, enabling it to break down fibrin, the primary protein component of blood clots.

While short-term use (up to four weeks) of serrapeptase is considered possibly safe for adults, there is a significant lack of reliable information regarding whether can serrapeptase be taken long term. The absence of comprehensive clinical studies on extended use leaves its long-term safety profile largely undetermined.

Serrapeptase is a proteolytic enzyme known for its anti-inflammatory properties, but its effect on blood coagulation raises a critical question: **does serrapeptase cause blood clots?** The evidence shows the exact opposite, as the enzyme acts as a fibrinolytic, and its use is associated with a risk of increased bleeding, not clotting.

Once commonly used for its anti-inflammatory effects in Europe, serratiopeptidase is no longer legally sold for human consumption in the EU and UK, following its classification as an unauthorized novel food under regulatory changes. The shift means that without a formal safety assessment and authorization, it cannot be legally placed on the market as a food supplement.